Propanc Biopharma (OTCMKTS:PPCB – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation. Earnings and Valuation This table compares Propanc […]
Propanc Biopharma, Inc. (OTCMKTS:PPCB – Get Free Report) saw a large decrease in short interest in December. As of December 31st, there was short interest totalling 100 shares, a decrease of 99.8% from the December 15th total of 59,300 shares. Based on an average daily trading volume, of 4,603,800 shares, the days-to-cover ratio is currently […]
Propanc Biopharma, Inc. (OTCMKTS:PPCB – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 59,300 shares, a growth of 352.7% from the November 30th total of 13,100 shares. Based on an average daily volume of 5,624,100 shares, […]
Propanc Biopharma (OTCMKTS:PPCB – Get Free Report) and Petros Pharmaceuticals (NASDAQ:PTPI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Analyst Recommendations This is a summary of […]
Propanc Biopharma, Inc. (OTCMKTS:PPCB – Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 35,000 shares, an increase of 18.2% from the September 30th total of 29,600 shares. Based on an average daily trading volume, of 802,500 […]